Onconetix Inc. (NASDAQ: ONCO)
$0.15
-0.0004 ( -0.27% ) 729.7K
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Market Data
Open
$0.15
Previous close
$0.15
Volume
729.7K
Market cap
$3.24M
Day range
$0.14 - $0.15
52 week range
$0.10 - $0.54
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Sep 22, 2023 |
8-k | 8K-related | 12 | Sep 08, 2023 |
8-k | 8K-related | 13 | Aug 28, 2023 |
8-k | 8K-related | 12 | Aug 22, 2023 |
nt | Quarterly Reports | 1 | Aug 15, 2023 |
8-k | 8K-related | 13 | Aug 10, 2023 |
8-k | 8K-related | 15 | Aug 03, 2023 |
8-k | 8K-related | 15 | Aug 01, 2023 |
8-k | 8K-related | 13 | Jul 31, 2023 |
8-k | 8K-related | 13 | Jul 25, 2023 |